dragon
Scopus Index (2026)

Medical journal of wuhan university

Medical journal of wuhan university (ISSN:1671-8852) is a monthly peer-reviewed scopus-indexed journal from 2001 to present. The publisher of this journal is Science China Press. Medical journal of wuhan university committed to gathering and disseminating excellent research achievements. The journal welcomes all types of General Medicine journal includes Medicine,Pharmacy, Bio-Chemistry, Psychology,Public Health Etc.

Medical journal of wuhan university

Submission Deadline

  • ( Vol 47 , Issue 04 ) | 26 Jun 2026

    Day
    Hour
    Min
    Sec

Publication Date

  • ( Vol 47 , Issue 04 ) | 30 Jun 2026

Aim And Scope

Medical journal of wuhan university

General Medicine, Pharmacy, Bio-Chemistry, Psychology Sciences and Public health:

Anatomy, Physiology, Biochemistry, Pharmacology, Pathology, Forensic medicine, Microbiology, Community Medicine, Otorhinolaryngology, Internal Medicine, General Surgery, Obstetrics and Gynecology, Radiology, Pulmonary Medicine, Dermatology and Venereal diseases, Infectious Diseases, Anaesthesia, Cancer research, Neurosurgery, Orthopedics, Gastroenterology, Neurology, Nephrology, Medical education, Orthopaedics, Paediatrics, Reproduction, Cardiology, Diabetes, Surgery, Nursing, Otolaryngology, Dental, Psychology, Anesthesiology, Dermatology,
Endocrinology, Hepatology, Urology, Venereology, Psychiatry, Biotechnology, Pharmacy, ENT, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutics, Pulmonology, Pharmacognosy, Pharmaceutical, Phatmaceutical Technology, Biopharmaceutics, Pharmacokinetics Pharmacodynamics, Industrial Pharmacy, Drug Design, Quality Assurance, Drug Regulatory Affairs, Phytochemistry, Drug Delivery Systems, Pharmaceutical Nanotechnology, Pharmaceutical Microbiology, Hospital Pharmacy, Clinical Pharmacy, Pharmacy Practice, Drug Discovery, Drug Metabolism, Toxicology, Clinical Research, Pharmacogenomics, Phrmacoinformatics, Pharmacovigilance, Life Sciences like Chemistry,
Biomedical Sciences, Microbiology, Immunology, Forensic, Epidemiology, Oncology, Biomedicine, Dentistry, Physiotherapy, Gynaecology, Dermatoepidemiology, Neuroscience, Ophthalmology, Sexology, Osteology, Kinesiology, Angiology/Vascular Medicine, Critical care Medicine, Haematology, Infectious Diseases and Vaccinology, Bariatrics, Pharmacy and Nursing, Pharmacognosy and Phytochemistry, Radiobiology, Clinical immunology, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Healthcare Services, Healthcare Management, Bioinformatics and Biotechnology, Geriatric Medicine,

Latest Paper Here

Medical journal of wuhan university
Advancements in pharmacological treatment of rosacea

Rosacea is a common chronic inflammatory skin disorder that mainly affects the central face. It is primarily characterized by recurrent episodes of flushing, persistent erythema, inflammatory papules, telangiectasias, phymatous changes, and ocular symptoms. Its pathogenesis is complex and still not completely understood. It encompasses innate and adaptive immune system dysregulation, neurovascular dysfunction, and genetic and environmental factors. To date, four subtypes of rosacea have been identified, based on the predominant clinical features: erythemato-teleangiectatic, papulopustular,

Effects of various exercise interventions on cognitive function in older adults with subjective memory complaints: A network meta-analysis

Physical exercise can slow down the decline of the cognitive function of the older adults, yet the review evidence is not conclusive. The purpose of this study was to compare the effects of aerobic and resistance training on cognitive ability. A computerized literature search was carried out using PubMed, Cochrane Library, Embase SCOPUS, Web of Science, CNKI (China National Knowledge Infrastructure), Wanfang, and VIP database to identify relevant articles from inception through to 1 October 2022. Based on a preliminary search of the database and the references cited, 10,338 records were ide

Clinical evaluation of oral methylprednone tablets on wound healing of facial atrophic acne after fractional carbon dioxide laser surgery

To observe the effect of oral methylprednone tablets on wound healing of facial atro⁃ phic acne after fractional carbon dioxide laser surgery. Methods: The data of outpatient dermatology cases in Xijing Hospital, Xi'an, China, was retrospectively analyzed, and the postoperative wound healing process of 103 patients with atrophic acne scars treated with fractional carbon dioxide laser from January 2019 to December 2021 was analyzed. The patients were divided into the observation group (treated with methylprednone tablet orally) and control group (treated without methylprednone tablets)

Effects of supramolecular salicylic acid on AMPK/mTOR pathway and autophagy in rats with acne model

The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway regulates cell proliferation, differentiation, and migration, along with angiogenesis and metabolism. Additionally, it could mediate skin development and homeostasis. There is much evidence to suggest that dysregulation of PI3K/Akt pathway is frequently associated with several human cutaneous malignancies like malignant melanoma (MM), basal cell carcinoma (BCC), and cutaneous squamous cell carcinoma (SCC), as well as their poor outcomes. Nevertheless, emerging roles of PI3K/Akt pathway cascade in a group of co

A controlled study of collagen type ⅩⅦ combined with fractional CO2 laser in the treatment of alopecia areata

Alopecia areata (AA) is a non-scarring autoimmune disease requiring long-term treatments. Topical, intralesional or systemic corticosteroids are the first option. However, considering the risk of skin atrophy and the possible lack of clinical response, new treatment options are urgently needed. A fractional carbon dioxide laser (FCL) has been proven to be effective alone or in combination with other drugs. However, no study has ever evaluated the association between FCL and topical tacrolimus. We report three cases of AA resistant to corticosteroids for at least 12 months, treated with topi

MJWU